000 01361 a2200385 4500
005 20250513033620.0
264 0 _c19950807
008 199508s 0 0 eng d
022 _a0006-3002
024 7 _a10.1016/0925-4439(95)00027-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLinnane, A W
245 0 0 _aThe universality of bioenergetic disease and amelioration with redox therapy.
_h[electronic resource]
260 _bBiochimica et biophysica acta
_cMay 1995
300 _a191-4 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCardiomyopathies
_xchemically induced
650 0 4 _aCoenzymes
650 0 4 _aHumans
650 0 4 _aMitochondria, Heart
_xdrug effects
650 0 4 _aMitochondrial Myopathies
_xchemically induced
650 0 4 _aMuscle, Skeletal
_xdrug effects
650 0 4 _aOxidation-Reduction
650 0 4 _aRats
650 0 4 _aSubmitochondrial Particles
_xmetabolism
650 0 4 _aUbiquinone
_xanalogs & derivatives
650 0 4 _aZidovudine
_xtoxicity
700 1 _aDegli Esposti, M
700 1 _aGenerowicz, M
700 1 _aLuff, A R
700 1 _aNagley, P
773 0 _tBiochimica et biophysica acta
_gvol. 1271
_gno. 1
_gp. 191-4
856 4 0 _uhttps://doi.org/10.1016/0925-4439(95)00027-2
_zAvailable from publisher's website
999 _c7598646
_d7598646